UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 275

Sortiert nach

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.542-549

2006

Volltextzugriff (PDF)

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

Journal of thrombosis and haemostasis, 2003-07, Vol.1 (7), p.1575-1579

2003

Volltextzugriff (PDF)

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Diabetologia, 2007-06, Vol.50 (6), p.1267-1276

2007

Volltextzugriff (PDF)

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

International Journal of Obesity, 2012-03, Vol.36 (3), p.422-430

2012

Volltextzugriff (PDF)

The CYP2C1917 allele is associated with better platelet response to clopidogrel in patients admitted for non‐ST acute coronary syndrome

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1409-1411

2009

Volltextzugriff (PDF)

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study

Circulation (New York, N.Y.), 2004-03, Vol.109 (11), p.1343-1348

2004

Volltextzugriff (PDF)

inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes

Diabetologia, 2009-06, Vol.52 (6), p.1152-1163

2009

Volltextzugriff (PDF)

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

International Journal of Obesity, 2015-06, Vol.39 (6), p.977-985

2015

Volltextzugriff (PDF)

Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.e533-e535

2017

Volltextzugriff (PDF)

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study

Clinical genetics, 2017-01, Vol.91 (1), p.131-136

2017

Volltextzugriff (PDF)

PAI-1, obesity, insulin resistance and risk of cardiovascular events

Thrombosis and haemostasis, 1997-07, Vol.78 (1), p.656

1997

Volltextzugriff (PDF)

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Diabetes (New York, N.Y.), 1997-05, Vol.46 (5), p.860

1997

Volltextzugriff (PDF)

Enhanced post‐clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1939-1941

2009

Volltextzugriff (PDF)

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study

Arteriosclerosis, thrombosis, and vascular biology, 2007-10, Vol.27 (10), p.2250

2007

Volltextzugriff (PDF)

Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha

The Journal of pathology, 2008-04, Vol.214 (5), p.574-583

2008

Volltextzugriff (PDF)

On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1174-1179

2005

Volltextzugriff (PDF)

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

Journal of internal medicine, 2004-04, Vol.255 (4), p.448-456

2004

Volltextzugriff (PDF)

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Arteriosclerosis, thrombosis, and vascular biology, 2002-05, Vol.22 (5), p.867

2002

Volltextzugriff (PDF)

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2671-2679

2010

Volltextzugriff (PDF)

Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men

American journal of physiology: endocrinology and metabolism, 2007-08, Vol.293 (2), p.E466-E474

2007

Volltextzugriff (PDF)

Plasminogen activator inhibitor type‐1 is an independent marker of metabolic disorders in young adults born small for gestational age

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2608-2613

2010

Volltextzugriff (PDF)

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

Arteriosclerosis, thrombosis, and vascular biology, 2000-04, Vol.20 (4), p.1150

2000

Volltextzugriff (PDF)

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort

British journal of haematology, 2005-01, Vol.128 (1), p.91-99

2005

Volltextzugriff (PDF)

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Diabetologia, 2001-11, Vol.44 (11), p.2025-2031

2001

Volltextzugriff (PDF)

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Circulation (New York, N.Y.), 1997-08, Vol.96 (3), p.761-768

1997

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Humans
(166)
Life Sciences & Biomedicine
(164)
Hematology
(91)
Female
(90)
Biological And Medical Sciences
(88)
Male
(88)
Cardiovascular System & Cardiology
(85)
Peripheral Vascular Disease
(83)
Middle Aged
(73)
Medical Sciences
(65)
Adult
(64)
Animals
(41)
Risk Factors
(35)
Aged
(34)
Fundamental And Applied Biological Sciences. Psychology
(27)
Insulin Resistance
(27)
Obesity
(27)
Fibrinolysis
(26)
Mice
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

The CYP2C1917 allele is associated with better platelet response to clopidogrel in patients admitted for non‐ST acute coronary syndrome

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study

inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study

PAI-1, obesity, insulin resistance and risk of cardiovascular events

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Enhanced post‐clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study

Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha

On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism

Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men

Plasminogen activator inhibitor type‐1 is an independent marker of metabolic disorders in young adults born small for gestational age

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Suchergebnisse filtern